This brand name is authorized in South Africa.
The drug PENILENTE FORTE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
RIT82F58GK - PENICILLIN G BENZATHINE
|
|
Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N'-dibenzylethylenediamine. Benzathine benzylpenicillin binds to penicillin binding proteins (PBP), the enzymes that catalyze the synthesis of peptidoglycan, a critical component of the bacterial cell wall. This leads to the interruption of cell wall synthesis, consequently leading to bacterial cell growth inhibition and cell lysis. |
|
2
|
UNII
YS5LY7JF4N - PENICILLIN G SODIUM
|
|
Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases. |
|
3
|
UNII
17R794ESYN - PENICILLIN G PROCAINE
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ZA | Health Products Regulatory Authority | A/20.1.2/824 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.